Literature DB >> 19720805

Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy?

M M Hoeper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720805     DOI: 10.1183/09031936.00094409

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

1.  Exacerbation of AIH in a patient with an AIH/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan.

Authors:  Reinhild Klein; Eva Hintz; Gerd Staehler
Journal:  BMJ Case Rep       Date:  2012-07-13

Review 2.  Potential Clinical Targets in Hepatopulmonary Syndrome: Lessons From Experimental Models.

Authors:  Sarah Raevens; Michael B Fallon
Journal:  Hepatology       Date:  2018-11       Impact factor: 17.425

Review 3.  The Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease.

Authors:  Rupesh Raina; Abigail Chauvin; Ronith Chakraborty; Nikhil Nair; Haikoo Shah; Vinod Krishnappa; Kirsten Kusumi
Journal:  Kidney Dis (Basel)       Date:  2019-12-18

Review 4.  Interplay of the Circadian Clock and Endothelin System.

Authors:  Lauren G Douma; Dominique Barral; Michelle L Gumz
Journal:  Physiology (Bethesda)       Date:  2021-01-01

5.  A cell permeable peptide targeting the intracellular loop 2 of endothelin B receptor reduces pulmonary hypertension in a hypoxic rat model.

Authors:  Daniel S Green; Chamila Rupasinghe; Rod Warburton; Jamie L Wilson; Christine O Sallum; Linda Taylor; Achani Yatawara; Dale Mierke; Peter Polgar; Nicholas Hill
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

6.  Toward Prospective Prediction of Pharmacokinetics in OATP1B1 Genetic Variant Populations.

Authors:  R Li; H A Barton; T S Maurer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.